Drawing for CLARAPATH

USPTO serial 88353342

CLARAPATH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LEE, OLIVIA SUNMIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLARAPATH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Dykeman

David J. Dykeman Greenberg Traurig, LLPOne International PlaceSuite 2000Boston, MA 02110

Goods and services

ClassDescriptionStatusFirst use
009Scientific research apparatus, namely, automated tissue sectioning apparatus, collection apparatus and preparation apparatus for research and diagnostic use for cancer testing, other tissue testing and other tissue analysisACTIVE—
010Automated apparatus for collecting and preparing tissue samples for pathology, histology or other tissue analysis for medical use; automated tissue sectioning apparatus for medical use; automated microtomy apparatus for cutting tissue samples for medical use; automated apparatus for transferring sectioned tissue samples to tape for medical use; automated apparatus for transferring tissue samples to slides for pathology, histology or other tissue analysis for medical use; automated apparatus for the preparation of tissue specimen glass slides for pathology, histology or other tissue analysis for medical use; diagnostic tissue specimen glass slides for collecting and storing tissue samples and materials for use with diagnostic glass slides for storing tissue samples; diagnostic tissue sample carrying tape for collecting and transferring multiple sectioned tissue specimens within the automated apparatusACTIVE—
042Medical laboratory services for tissue sectioning, collection and preparation; preparation of tissue sample slides for research and testing for scientific and medical research purposes; pathology and histology laboratory services; tissue testing services for scientific and medical research purposes; tissue analysis services for scientific and medical research purposesACTIVE—
044Medical testing of tissue samples for diagnostic purposes; medical testing of tissue samples for treatment purposes; medical analysis services including tissue preparation and analysis for diagnostic, pathology, histology and treatment purposes; tissue diagnostic testing services for medical purposes; tissue testing services for medical purposes; tissue analysis services for medical purposes; tissue imaging and data storage for diagnostic services and analysis for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 12, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 12, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 6, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 5, 2022EX5GSOU EXTENSION 5 GRANTED—
May 3, 2022EXT5SOU EXTENSION 5 FILED—
May 3, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2021EX4GSOU EXTENSION 4 GRANTED—
Nov 3, 2021EXT4SOU EXTENSION 4 FILED—
Nov 3, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 4, 2021EX3GSOU EXTENSION 3 GRANTED—
May 4, 2021EXT3SOU EXTENSION 3 FILED—
May 4, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2020EX2GSOU EXTENSION 2 GRANTED—
Nov 4, 2020EXT2SOU EXTENSION 2 FILED—
Nov 4, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 1, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 31, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 28, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Aug 28, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 28, 2020PETGPETITION TO REVIVE-GRANTED—
Aug 28, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Aug 3, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 11, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 29, 2020LEXTLATE FILED EXTENSION REQUEST—
May 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 5, 2020EXT1SOU EXTENSION 1 FILED—
Nov 5, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 10, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 8, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Aug 8, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 8, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 8, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 26, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 16, 2019PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 25, 2019ALIEASSIGNED TO LIE—
Jun 17, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jun 17, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 17, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 17, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
May 28, 2019DOCKASSIGNED TO EXAMINER—
Apr 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance